EraGen Again Moving Multiplex Assays Toward Clinic in Wake of Luminex Separation
May 27, 2010
EraGen Again Moving Multiplex Assays Toward Clinic in Wake of Luminex Separation
Following the dissolution last year of a longstanding relationship with Luminex, EraGen is once again eyeing the IVD market for its multiplex PCR assay reagents by partnering with other companies offering bead-based detection systems.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Recent Studies Prop Up Multiplex PCR Testing for Respiratory Viruses
May 26, 2010 / PCR Insider - EraGen to Develop Multiplex MDx Tests on Applied BioCode Platform
April 21, 2011 / PCR Insider - Luminex Looks to Target Mid- to Low-Volume MDx Labs with GenturaDx Platform
July 12, 2012 / PCR Insider - Real-Time PCR Chemistries Key to Luminex's $34M EraGen Acquisition
June 23, 2011 / PCR Insider - Luminex in Alpha Stage for New MDx Platform; Ups R&D Spending to Prep for Market
May 2, 2013 / PCR Insider